Efficacy and safety of MK-1293 insulin glargine compared with originator insulin glargine (Lantus) in type 2 diabetes: A randomized, open-label clinical trial

DSpace Repository

Efficacy and safety of MK-1293 insulin glargine compared with originator insulin glargine (Lantus) in type 2 diabetes: A randomized, open-label clinical trial

Author: Hollander, Priscilla A.; Carofano, Wendy L.; Lam, Raymond L. H.; Golm, Gregory T.; Eldor, Roy; Crutchlow, Michael F.; Marcos, Michael C.; Rendell, Marc S.; Home, Philip D.; Gallwitz, Baptist; Rosenstock, Julio
Tübinger Autor(en):
Gallwitz, Baptist
Published in: Diabetes Obesity & Metabolism (2018), Bd. 20, H. 9, S. 2229-2237
Verlagsangabe: Wiley
Language: English
Full text: http://dx.doi.org/10.1111/dom.13363
ISSN: 1463-1326
DDC Classifikation: 610 - Medicine and health
Dokumentart: Artikel
Show full item record

This item appears in the following Collection(s)